Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)

BACKGROUND: Immune-Oncology (IO) improves Overall Survival (OS) in metastatic Renal Cell Carcinoma (mRCC). The prognostic impact of previous Cytoreductive Nephrectomy (CN) and radical nephrectomy (RN), with curative intent, in patients treated with IO is not well defined. The aim of our paper is to...

Descripción completa

Detalles Bibliográficos
Autores principales: Stellato, Marco, Santini, Daniele, Verzoni, Elena, De Giorgi, Ugo, Pantano, Francesco, Casadei, Chiara, Fornarini, Giuseppe, Maruzzo, Marco, Sbrana, Andrea, Di Lorenzo, Giuseppe, Soraru, Mariella, Naglieri, Emanuele, Buti, Sebastiano, De Vivo, Rocco, Napolitano, Andrea, Vignani, Francesca, Mucciarini, Claudia, Grillone, Francesco, Roviello, Giandomenico, Di Napoli, Marilena, Procopio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217989/
https://www.ncbi.nlm.nih.gov/pubmed/34168997
http://dx.doi.org/10.3389/fonc.2021.682449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217989/
https://www.ncbi.nlm.nih.gov/pubmed/34168997
http://dx.doi.org/10.3389/fonc.2021.682449

Ejemplares similares